Larry L. Wood - Feb 16, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP & Grp President TAVR & SSH
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Feb 16, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/17/2023, 05:35 PM
Previous filing: Dec 13, 2022
Next filing: May 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+3.24K	+1.6%	$0.00	205K	Feb 16, 2023	Direct	F1
holding	EW	Common Stock						496	Feb 16, 2023	401(k)	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on February 16, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
F2	Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.